Lonza
Owen Rees is a Senior Bioprocess Engineer at Lonza since April 2022, with prior experience as a Manufacturing Technology Scientist/Engineer at Bristol-Myers Squibb from November 2018 to February 2022. Key achievements include authoring development and engineering protocols, leading gap analysis projects, completing protocol deviations, and supporting cross-functional departments. Prior to Bristol-Myers Squibb, Owen served as a Biotechnician at BioMarin Pharmaceutical Inc., where expertise in perfusion bioreactors was demonstrated, along with training and QA validation experience. Educational qualifications include a Master’s degree in Computational Biology and a Bachelor’s degree in Pharmaceutical Biotechnology from Munster Technological University.
Previous companies
This person is not in any teams
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.